Published in Drug Law Weekly, January 16th, 2007
"We are pleased to have the opportunity to obtain feedback and guidance from the FDA on our pivotal trial," stated Mark Ahn, PhD, president and CEO. "We believe this regulatory mechanism provides an important step forward in our clinical development for Marqibo."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.